Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2015, Article ID 614297, 10 pages
http://dx.doi.org/10.1155/2015/614297
Research Article

Regulatory T Cells Resist Cyclosporine-Induced Cell Death via CD44-Mediated Signaling Pathways

1Division of Infectious Diseases and Geographic Medicine, Department of Medicine, 300 Pasteur Drive, Stanford University School of Medicine, Stanford, CA 94305-5107, USA
2Benaroya Research Institute, 1201 Ninth Avenue, Seattle, WA 98101, USA

Received 27 September 2014; Revised 19 January 2015; Accepted 19 January 2015

Academic Editor: Rony Seger

Copyright © 2015 Shannon M. Ruppert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. S. Wildin, F. Ramsdell, J. Peake et al., “X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy,” Nature Genetics, vol. 27, no. 1, pp. 18–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. E. N. Huter, G. A. Punkosdy, D. D. Glass, L. I. Cheng, J. M. Ward, and E. M. Shevach, “TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice,” European Journal of Immunology, vol. 38, no. 7, pp. 1814–1821, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. K. Selvaraj and T. L. Geiger, “Mitigation of experimental allergic encephalomyelitis by TGF-β induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance,” Journal of Immunology, vol. 180, no. 5, pp. 2830–2838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Y. Wuest, J. Willette-Brown, S. K. Durum, and A. A. Hurwitz, “The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells,” Journal of Leukocyte Biology, vol. 84, no. 4, pp. 973–980, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. Chen, Y. C. Kim, A. Laurence, G. A. Punkosdy, and E. M. Shevach, “IL-2 controls the stability of Foxp3 expression in TGF-β-induced Foxp3+ T cells in vivo,” The Journal of Immunology, vol. 186, no. 11, pp. 6329–6337, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Sakaguchi, R. Setoguchi, H. Yagi, and T. Nomura, “Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease,” Current Topics in Microbiology and Immunology, vol. 305, pp. 51–66, 2006. View at Google Scholar · View at Scopus
  7. R. Setoguchi, S. Hori, T. Takahashi, and S. Sakaguchi, “Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization,” The Journal of Experimental Medicine, vol. 201, no. 5, pp. 723–735, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Zorn, E. A. Nelson, M. Mohseni et al., “IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo,” Blood, vol. 108, no. 5, pp. 1571–1579, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. de la Rosa, S. Rutz, H. Dorninger, and A. Scheffold, “Interleukin-2 is essential for CD4+CD25+ regulatory T cell function,” European Journal of Immunology, vol. 34, no. 9, pp. 2480–2488, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Liao, J.-X. Lin, L. Wang, P. Li, and W. J. Leonard, “Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages,” Nature Immunology, vol. 12, no. 6, pp. 551–559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. T. R. Malek, A. Yu, L. Zhu, T. Matsutani, D. Adeegbe, and A. L. Bayer, “IL-2 family of cytokines in T regulatory cell development and homeostasis,” Journal of Clinical Immunology, vol. 28, no. 6, pp. 635–639, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. L. M. Anderson, T. C. Dumsha, N. J. McDonald, and J. K. Spitznagel Jr., “Evaluating IL-2 levels in human pulp tissue,” Journal of Endodontics, vol. 28, no. 9, pp. 651–655, 2002. View at Publisher · View at Google Scholar
  13. O. Lesur, A. Kokis, C. Hermans, T. Fülöp, A. Bernard, and D. Lane, “Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival,” Critical Care Medicine, vol. 28, no. 12, pp. 3814–3822, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. T. M. Phillips, “Measurement of total and bioactive interleukin-2 in tissue samples by immunoaffinity-receptor affinity chromatography,” Biomedical Chromatography, vol. 11, no. 4, pp. 200–204, 1997. View at Google Scholar
  15. A. N. Akbar, M. Vukmanovic-Stejic, L. S. Taams, and D. C. Macallan, “The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery,” Nature Reviews Immunology, vol. 7, no. 3, pp. 231–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Vukmanovic-Stejic, Y. Zhang, A. N. Akbar, and D. C. Macallan, “Measurement of proliferation and disappearance of regulatory T cells in human studies using deuterium-labeled glucose,” Methods in Molecular Biology, vol. 707, pp. 243–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. H. G. Kang, D. Zhang, N. Degauque, C. Mariat, S. Alexopoulos, and X. X. Zheng, “Effects of cyclosporine on transplant tolerance: the role of IL-2,” American Journal of Transplantation, vol. 7, no. 8, pp. 1907–1916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Liu, J. D. Farmer Jr., W. S. Lane, J. Friedman, I. Weissman, and S. L. Schreiber, “Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes,” Cell, vol. 66, no. 4, pp. 807–815, 1991. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-W. Chow, M. Rincón, and R. J. Davis, “Requirement for transcription factor NFAT in interleukin-2 expression,” Molecular and Cellular Biology, vol. 19, no. 3, pp. 2300–2307, 1999. View at Google Scholar · View at Scopus
  20. W. Gao, Y. Lu, B. El Essawy, M. Oukka, V. K. Kuchroo, and T. B. Strom, “Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells,” The American Journal of Transplantation, vol. 7, no. 7, pp. 1722–1732, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. E. F. Knol, I. M. Haeck, A. A. van Kraats et al., “Modulation of lymphocyte function In Vivo via inhibition of calcineurin or purine synthesis in patients with atopic dermatitis,” Journal of Investigative Dermatology, vol. 132, no. 10, pp. 2476–2479, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Y. Li, Q. Wu, Z. Yan et al., “Prevention of acute GVHD in mice by treatment with Tripterygium hypoglaucum Hutch combined with cyclosporin A,” Hematology, vol. 18, no. 6, pp. 352–359, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Meloni, M. Morosini, N. Solari et al., “Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors,” International Immunopharmacology, vol. 6, no. 13-14, pp. 2002–2010, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Stern, A. A. Asari, and K. N. Sugahara, “Hyaluronan fragments: an information-rich system,” European Journal of Cell Biology, vol. 85, no. 8, pp. 699–715, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Firan, S. Dhillon, P. Estess, and M. H. Siegelman, “Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44,” Blood, vol. 107, no. 2, pp. 619–627, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. P. L. Bollyky, B. A. Falk, R. P. Wu, J. H. Buckner, T. N. Wight, and G. T. Nepom, “Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells,” Journal of Leukocyte Biology, vol. 86, no. 3, pp. 567–572, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. P. L. Bollyky, J. D. Lord, S. A. Masewicz et al., “Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells,” Journal of Immunology, vol. 179, no. 2, pp. 744–747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. P. L. Bollyky, B. A. Falk, S. A. Long et al., “CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta,” Journal of Immunology, vol. 183, no. 4, pp. 2232–2241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Liu, L. Soong, G. Liu, R. König, and A. K. Chopra, “CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells,” Biology Direct, vol. 4, article 40, 2009. View at Publisher · View at Google Scholar
  30. C. Koenecke, N. Czeloth, A. Bubke et al., “Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD,” European Journal of Immunology, vol. 39, no. 11, pp. 3091–3096, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Kakizaki, K. Kojima, K. Takagaki et al., “A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone,” The Journal of Biological Chemistry, vol. 279, no. 32, pp. 33281–33289, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Glazier, P. J. Tutschka, E. R. Farmer, and G. W. Santos, “Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution,” The Journal of Experimental Medicine, vol. 158, no. 1, pp. 1–8, 1983. View at Publisher · View at Google Scholar · View at Scopus
  33. E. K. Gao, D. Lo, R. Cheney, O. Kanagawa, and J. Sprent, “Abnormal differentiation of thymocytes in mice treated with cyclosporin A,” Nature, vol. 336, no. 6195, pp. 176–179, 1988. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Wu, T. Thalhamer, R. F. Franca et al., “Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells,” Immunity, vol. 41, no. 2, pp. 270–282, 2014. View at Publisher · View at Google Scholar
  35. B. J. G. Baaten, C.-R. Li, M. F. Deiro, M. M. Lin, P. J. Linton, and L. M. Bradley, “CD44 regulates survival and memory development in Th1 cells,” Immunity, vol. 32, no. 1, pp. 104–115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. A. de Serres, M. H. Sayegh, and N. Najafian, “Immunosuppressive drugs and tregs: a critical evaluation!,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 10, pp. 1661–1669, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. C. C. Baan, B. J. Van Der Mast, M. Klepper et al., “Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells,” Transplantation, vol. 80, no. 1, pp. 110–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Miroux, O. Moralès, A. Carpentier et al., “Inhibitory effects of cyclosporine on human regulatory T cells in vitro,” Transplantation Proceedings, vol. 41, no. 8, pp. 3371–3374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Zeiser, V. H. Nguyen, A. Beilhack et al., “Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production,” Blood, vol. 108, no. 1, pp. 390–399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Wu, L. Zhang, K. Xu et al., “Immunosuppressive drugs on inducing Ag-specific CD4+CD25+Foxp3+ Treg cells during immune response in vivo,” Transplant Immunology, vol. 27, no. 1, pp. 30–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Miroux, O. Morales, K. Ghazal et al., “In vitro effects of cyclosporine a and tacrolimus on regulatory T-cell proliferation and function,” Transplantation, vol. 94, no. 2, pp. 123–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Kawai, H. Kitade, C. Mathieu, M. Waer, and J. Pirenne, “Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo,” Transplantation, vol. 79, no. 9, pp. 1073–1077, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. J. D. Goldstein, R. S. Balderas, and G. Marodon, “Continuous activation of the CD122/STAT-5 signaling pathway during selection of antigen-specific regulatory T cells in the murine thymus,” PLoS ONE, vol. 6, no. 4, Article ID e19038, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. M. Thornton, “Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2,” Frontiers in Bioscience, vol. 11, no. 1, pp. 921–927, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. T. R. Malek, “The biology of interleukin-2,” Annual Review of Immunology, vol. 26, no. 1, pp. 453–479, 2008. View at Publisher · View at Google Scholar
  46. A. Antov, L. Yang, M. Vig, D. Baltimore, and L. van Parijs, “Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance,” The Journal of Immunology, vol. 171, no. 7, pp. 3435–3441, 2003. View at Publisher · View at Google Scholar · View at Scopus